Trial Profile
Arterial lipiodolised chemotherapy [ethiodized oil + cisplatin] versus systemic chemotherapy with gemcitabine plus oxaliplatin (GEMOX) versus no treatment following surgical resection or local ablation of hepatocellular carcinoma in cirrhotic patients
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Jun 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Ethiodized oil (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms GEMOXIAL
- 08 May 2011 Status changed from not yet recruiting to discontinued.
- 16 May 2007 New trial record.